Drug Shortage Report for RYBELSUS
| Report ID | 214721 |
| Drug Identification Number | 02497611 |
| Brand name | RYBELSUS |
| Common or Proper name | RYBELSUS |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SEMAGLUTIDE |
| Strength(s) | 14MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | A10BJ |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-01-05 |
| Actual start date | 2024-01-05 |
| Estimated end date | 2024-01-09 |
| Actual end date | 2024-01-09 |
| Shortage status | Resolved |
| Updated date | 2024-01-10 |
| Company comments | supply remains at the wholesale level |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-01-10 | English | Compare |
| v5 | 2024-01-09 | French | Compare |
| v4 | 2024-01-09 | English | Compare |
| v3 | 2024-01-06 | English | Compare |
| v2 | 2024-01-03 | French | Compare |
| v1 | 2024-01-03 | English | Compare |
Showing 1 to 6 of 6